GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLN) » Definitions » Net Interest Income (for Banks)

Actelion (XSWX:ATLN) Net Interest Income (for Banks)


View and export this data going back to 2000. Start your Free Trial

What is Actelion Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Actelion (XSWX:ATLN) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.